Let Worldwide Move Your Discoid Lupus Treatment Forward

Discoid lupus erythematosus (DLE) can leave scars that are more than skin deep. Typically appearing on the face, neck, and scalp, the skin lesions associated with DLE often are painless, but they can be difficult to hide and can grow worse if exposed to the sun. In some cases, the condition will improve on its own; in other cases, it can progress to systemic lupus erythematosus (SLE), which can have a devastating effect on organs and bodily functions.

No one knows for sure what causes DLE, but research is underway to mitigate, if not wholly prevent, the complications DLE can cause. In that fight, Worldwide Clinical Trials stands as the CRO best positioned to help you bring your work to the next step.

With more than 30 years of experience supporting researchers working in immune-mediated inflammatory disorders (IMID), Worldwide is an internationally acclaimed expert in clinical trial management. We offer full-service support for Phase I-Phase IV clinical trials, as well as real-world evidence clinical research services that can monitor the near- and long-term effects of the treatment you are developing.

DLE researchers working with Worldwide can rest easy knowing that they will be working with a stable team of project professionals who are already experienced in IMID research. Whether you are looking for insightful feedback on development plans, detailed and expert feasibility analyses, or the resources and management skills required to bring your project to fruition on-time and on-budget, you will find the support you need at Worldwide.